Argyrios Stampas (IMAGE)

University of Texas Health Science Center at Houston

Argyrios Stampas

Caption

Argyrios Stampas, MD, MS, leads the Houston site of a clinical trial investigating a modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury.

Credit

UTHealth Houston

Usage Restrictions

with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.